Sunday, December 07, 2025 | 10:28 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

India in talks with EU, Australia and Japan to allay TRIPS waiver concerns

Last October, India and South Africa had submitted a joint proposal for temporarily waiving sections of TRIPS to help more countries, especially middle and low income ones access Covid-19 vaccines

Along with shorter-lasting antibodies, Covid vaccines also trigger what’s essentially a long-term memory in the immune system. (Photo: Bloomberg)
premium

Some of the member nations had reservations that the TRIPS agreement has inbuilt flexibilities, which allows use of compulsory licensing mechanisms and there is no requirement for a waiver

Shreya Nandi New Delhi
India is trying to alleviate the concerns of a bunch of developed nations such as Australia, Japan and the regional bloc, and the European Union (EU), regarding its proposal at the World Trade Organization (WTO) towards temporary patent waiver on Covid-19 vaccines and drugs.

In October 2020, India and South Africa had submitted a joint proposal for temporarily waiving some sections of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement, to help more countries, especially middle and low income nations get access to Covid-19 vaccines. It will be applicable to industrial design, trade secrets, patents and copyrights.

As of